Bioorthogonal Small Molecule Imaging Agents Allow Single-Cell Imaging of MET
View/ Open
Published Version
https://doi.org/10.1371/journal.pone.0081275Metadata
Show full item recordCitation
Kim, Eunha, Katherine S. Yang, and Ralph Weissleder. 2013. “Bioorthogonal Small Molecule Imaging Agents Allow Single-Cell Imaging of MET.” PLoS ONE 8 (11): e81275. doi:10.1371/journal.pone.0081275. http://dx.doi.org/10.1371/journal.pone.0081275.Abstract
The hepatocyte growth factor receptor (MET) is a receptor tyrosine kinase (RTK) that has emerged as an important cancer target. Consequently, a number of different inhibitors varying in specificity are currently in clinical development. However, to date, it has been difficult to visualize MET expression, intracellular drug distribution and small molecule MET inhibition. Using a bioorthogonal approach, we have developed two companion imaging drugs based on both mono- and polypharmacological MET inhibitors. We show exquisite drug and target co-localization that can be visualized at single-cell resolution. The developed agents may be useful chemical biology tools to investigate single-cell pharmacokinetics and pharmacodynamics of MET inhibitors.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827223/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:11879093
Collections
- HMS Scholarly Articles [17917]
Contact administrator regarding this item (to report mistakes or request changes)